In the News
Creative Loafing | Q&A: On vulvodynia with Emory Associate Professor of Gynecology, Dr. Kevin Ault
April 20, 2012, by Melysa Martinez
Kevin Ault, MD, associate professor of gynecology and obstetrics at Emory University School of Medicine, gave an interview on vulvodynia, a syndrome that affects 13 million woman a year.
Does HPV Affect African American Women Differently? WABE 90.1 FM, Thursday, April 5, 2012, Atlanta, Georgia
New research suggests there might be a difference in the time it takes for white women and African American women to fight off HPV infections. But most findings point to access to health care services as the main problem. Kevin Ault, an HPV expert at Emory University and Grady Hospital, says there’s a bigger issue that has less to do with race. “We know that everybody that’s sexually active is at risk for HPV, so that doesn’t vary from demographic to demographic,” he says. But what does vary is access to health services like pap smears. He says the issue is especially a problem in Atlanta, where Fulton County’s rates for cervical cancer are twice the national average.
Modeling Disparities May Help With Cervical Cancer Prevention Researchers reported that explicit inclusion of disparities in cost-effectiveness analysis, would allow policy makers to identify strategies that would reduce overall cancer risk, reduce disparities between racial ethnic subgroups, and be cost-effective, according to a study published online Sept. 6 in the Journal of the National Cancer Institute. In an accompanying editorial, Kevin A. Ault, MD, ... adds that since recent research has identified HPV vaccination and diagnostic testing as potential improvements to the Pap smear in cervical cancer prevention, these strategies should be made available to all women.
"Looking at a patient's history of estrogen use may be an important factor in (gauging) their risk for developing urinary incontinence," said Dr. Gina Northington, an author of the study who specializes in urogynecology at Emory University in Atlanta. Northington GM, de Vries HF, Bogner HR. Self-reported estrogen use and newly incident urinary incontinence among postmenopausal community-dwelling women. Menopause. 2011 Oct 1. [Epub ahead of print].
Prolonged Use of Estrogen Leads to Reports of Urinary Incontinence. Researchers have found that postmenopausal women who reported taking postmenopausal hormone therapy with estrogen for five years or more were more likely to develop urinary incontinence (UI) than were women who took estrogen for less than five years or not at all. “The incidence of urinary incontinence increases as a woman ages and after menopause,” says (Gina) Northington. “Results from the Women’s Health Initiative (WHI) and other observational studies have shown a relationship between the use of postmenopausal HRT and incident urinary incontinence during follow-up. However, many of these studies were conducted in largely homogeneous populations without looking at patients’ other health conditions.” the article was published online in Menopause: The Journal of the North American Menopause Society on Oct. 13, 2011. It will be published in print in the March 2012 (Volume 19, Issue 3) edition of the journal.
From: Emory in the News, October 18, 2011.
HealthNewsDigest.com | New study tests most effective way to warm newborns after first bath
November 11, 2011
We have been looking at the effectiveness of skin-to-skin contact and warming infants from the breast feeding perspective," says Sino George, RNC, MSN, WHNP-BC, clinical nurse specialist in Emory's Women's Center and principal investigator of this clinical trial.
Modeling Disparities May Help With Cervical Cancer Prevention
Researchers reported that explicit inclusion of disparities in cost-effectiveness analysis, would allow policy makers to identify strategies that would reduce overall cancer risk, reduce disparities between racial ethnic subgroups, and be cost-effective, according to a study published online Sept. 6 in the Journal of the National Cancer Institute.
In an accompanying editorial, Kevin A. Ault, M.D., of the Department of Gynecology and Obstetrics at Emory University School of Medicine writes that the introduction of the HPV vaccines into the world of medicine has made cervical cancer prevention a reality. Ault agrees with the study’s conclusions on the utility of modeling, particularly that, “modeling of racial and ethnic subgroups at increased risk identifies strategies that can reduce cancer burden among these groups.” Ault adds that since recent research has identified HPV vaccination and diagnostic testing as potential improvements to the Pap smear in cervical cancer prevention, these strategies should be made available to all women.
Mary Dolan, MD, MPH was selected by Department of Health and Human Services Secretary Kathleen Sebelius to serve a four-year term on the Breast and Cervical Cancer Early Detection and Control Advisory Committee of the Centers for Disease Control and Prevention.
Emory Ob/Gyn Researcher Dr. Fritz Wieser and Colleagues Receive NIH Funding to Study Potential of Curcumin Analogs for Treatment of Endometriosis.
Emory Gynecology ranked #22 in Nation in the 2010-2011 U.S. News & World Report.